Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
RAPTRapt Therapeutics	$1.68bn	n/a	n/a
NUVBNuvation Bio	$1.67bn	n/a	n/a
PVLAPalvella Therapeutics	$1.66bn	n/a	n/a
IOVAIovance Biotherapeutics	$1.65bn	n/a	n/a
RXRXRecursion Pharmaceuticals	$1.65bn	n/a	n/a
INBXInhibrx Biosciences	$1.62bn	n/a	n/a
GLUEMonte Rosa Therapeutics	$1.59bn	n/a	n/a
ATAIAtaiBeckley	$1.59bn	n/a	n/a
TSHATaysha Gene Therapies	$1.59bn	n/a	n/a
ABCLAbCellera Biologics	$1.57bn	n/a	n/a
ARDXArdelyx	$1.57bn	n/a	n/a
QUREUniqure NV	$1.56bn	n/a	n/a
AMLXAmylyx Pharmaceuticals	$1.55bn	n/a	n/a
DMRADamora Therapeutics	$1.53bn	n/a	n/a
VIRVir Biotechnology	$1.52bn	n/a	n/a
MBXMBX Biosciences	$1.51bn	n/a	n/a
IMTXImmatics NV	$1.51bn	n/a	n/a
GHRSGH Research	$1.49bn	n/a	n/a
NVAXNovavax	$1.48bn	662.24	n/a
URGNUrogen Pharma	$1.46bn	n/a	n/a